Joseph P. St. Laurent,Gerald S. Jones,David M. Breese
申请号：
US14958165
公开号：
US09439880B2
申请日:
2015.12.03
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention is directed to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and ω-(methylsulfonyl)alkylamine or ω-(methylsulfonyl)alkylamide. The present invention is also directed to a method for treating inflammation, inflammatory-related disorders, or pain, by administering ω-(methylsulfonyl)alkylamine or ω-(methylsulfonyl)alkylamide, or a pharmaceutically acceptable salt or solvate thereof to a subject in need thereof.
